Use of Nintedanib and Pirfenidone in Non-Idiopathic Pulmonary Fibrosis Lung Disease

Am J Respir Crit Care Med. 2021 Jul 1;204(1):92-94. doi: 10.1164/rccm.202012-4356RR.
No abstract available

Publication types

  • Comment

MeSH terms

  • Humans
  • Indoles / therapeutic use
  • Lung Diseases*
  • Pyridones* / therapeutic use

Substances

  • Indoles
  • Pyridones
  • pirfenidone
  • nintedanib